Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online February 8, 2021.
Article Versions
- Earlier version (July 2, 2020 - 07:48).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2021 by the American Society of Nephrology
Author Information
- David J. Friedman, and
- Martin R. Pollak
- Division of Nephrology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
- Correspondence:
Dr. David J. Friedman or Dr. Martin R. Pollak, Division of Nephrology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215. Email: dfriedma{at}bidmc.harvard.edu or mpollak{at}bidmc.harvard.edu
Funding
National Center on Minority Health and Health Disparities
NIHMD
Statistics from Altmetric.com
Article usage
In this issue
APOL1 Nephropathy: From Genetics to Clinical Applications
Jump to section
- Article
- Abstract
- Introduction
- APOL1 Biology: The Basics
- APOL1 Nephropathy: One Gene, Many Diseases across the APOL1 Spectrum
- APOL1 Risk Variants in Children
- Global Burden of APOL1 Nephropathy
- How Common Is APOL1-Associated Kidney Disease?
- Transplantation: From Mechanism to Clinical Utility
- Triggers of APOL1 Kidney Disease: Beyond Susceptibility
- CKD and ESKD: When Is It APOL1 Nephropathy?
- The Special Case of Diabetic Kidney Disease
- Using APOL1 to Improve Hypertension and CKD Regimens
- Therapeutic Approaches to APOL1 Kidney Disease
- Disclosures
- Funding
- Footnotes
- References
- Figures & Data Supps
- Info & Metrics
- View PDF